COVID-19: Remdesivir gets conditional EU clearance, becomes region’s first authorised therapy to treat virus
The European Commission, EU, said on Friday it had given conditional approval for the use of antiviral remdesivir in severe COVID-19 patients following an accelerated review process, making it the…
EU gives green light for use of Remdesivir, first COVID-19 drug
The first drug to treat severe cases of COVID-19 in the EU on Friday was given the green light, with the European Commission approving remdesivir. The EU’s Health Commissioner, Stella…